Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas M Pajewski

Showing results (111-120 of 160) with videos related to

Pageof 16
Sort By:
Obesity (Silver Spring, Md.)|October 27, 2025
Application of the Lancet Commission Criteria for the Diagnosis of Obesity to a Clinical Trials Population: The LEAP TrialFaith Anne N Heeren, Kathleen R Ruddiman, Courtney Simmons, et al.
Plos One|September 9, 2011
Genome-wide detection of allele specific copy number variation associated with insulin resistance in African Americans from the HyperGEN studyMarguerite R Irvin, Nathan E Wineinger, Treva K Rice, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|February 13, 2025
Effect of initiation and continuous adherence to ARBs vs. ACEIs on risk of adjudicated mild cognitive impairment or dementiaCatherine G Derington, Ransmond O Berchie, Daniel O Scharfstein, et al.
Kidney International|July 17, 2014
Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention TrialCarl D Langefeld, Jasmin Divers, Nicholas M Pajewski, et al.
Hypertension (Dallas, Tex. : 1979)|October 29, 2025
Effect of Intensive Systolic Blood Pressure Control on Markers of Cerebral Small Vessel Disease by AgeJeremy J Pruzin, Wai-Ying Wendy Yau, Adam P Bress, et al.
Human Genetics|March 30, 2017
Genetic associations with lipoprotein subfraction measures differ by ethnicity in the multi-ethnic study of atherosclerosis (MESA)Zhe Wang, Ani Manichukal, David C Goff, et al.
Journal of the American Society of Nephrology : JASN|June 28, 2020
Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention TrialManjula Kurella Tamura, Sarah A Gaussoin, Nicholas M Pajewski, et al.
American Journal of Nephrology|August 12, 2016
Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration DefinitionsMichael V Rocco, Arlene Chapman, Glenn M Chertow, et al.
Journal of the American Geriatrics Society|January 10, 2017
Effect of a Long-Term Intensive Lifestyle Intervention on Cognitive Function: Action for Health in Diabetes StudyStephen R Rapp, Jose A Luchsinger, Laura D Baker, et al.
Hypertension (Dallas, Tex. : 1979)|July 3, 2024
High-Sensitivity Troponin T, NT-proBNP, and Cognitive Outcomes in SPRINTDevin Haney, Yuan Ma, Djhenne Dalmacy, et al.
Pageof 16

Showing results (111-120 of 160) with videos related to

Sort By:
Pageof 16
Obesity (Silver Spring, Md.)|October 27, 2025
Application of the Lancet Commission Criteria for the Diagnosis of Obesity to a Clinical Trials Population: The LEAP TrialFaith Anne N Heeren, Kathleen R Ruddiman, Courtney Simmons, et al.
Plos One|September 9, 2011
Genome-wide detection of allele specific copy number variation associated with insulin resistance in African Americans from the HyperGEN studyMarguerite R Irvin, Nathan E Wineinger, Treva K Rice, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|February 13, 2025
Effect of initiation and continuous adherence to ARBs vs. ACEIs on risk of adjudicated mild cognitive impairment or dementiaCatherine G Derington, Ransmond O Berchie, Daniel O Scharfstein, et al.
Kidney International|July 17, 2014
Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention TrialCarl D Langefeld, Jasmin Divers, Nicholas M Pajewski, et al.
Hypertension (Dallas, Tex. : 1979)|October 29, 2025
Effect of Intensive Systolic Blood Pressure Control on Markers of Cerebral Small Vessel Disease by AgeJeremy J Pruzin, Wai-Ying Wendy Yau, Adam P Bress, et al.
Human Genetics|March 30, 2017
Genetic associations with lipoprotein subfraction measures differ by ethnicity in the multi-ethnic study of atherosclerosis (MESA)Zhe Wang, Ani Manichukal, David C Goff, et al.
Journal of the American Society of Nephrology : JASN|June 28, 2020
Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention TrialManjula Kurella Tamura, Sarah A Gaussoin, Nicholas M Pajewski, et al.
American Journal of Nephrology|August 12, 2016
Chronic Kidney Disease Classification in Systolic Blood Pressure Intervention Trial: Comparison Using Modification of Diet in Renal Disease and CKD-Epidemiology Collaboration DefinitionsMichael V Rocco, Arlene Chapman, Glenn M Chertow, et al.
Journal of the American Geriatrics Society|January 10, 2017
Effect of a Long-Term Intensive Lifestyle Intervention on Cognitive Function: Action for Health in Diabetes StudyStephen R Rapp, Jose A Luchsinger, Laura D Baker, et al.
Hypertension (Dallas, Tex. : 1979)|July 3, 2024
High-Sensitivity Troponin T, NT-proBNP, and Cognitive Outcomes in SPRINTDevin Haney, Yuan Ma, Djhenne Dalmacy, et al.
Pageof 16